All results
1 results for randomized double blind placebo controlled study erlotinib or placebo patients
-
FASTEST Trial
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute…
- Ages
- 18 Years - 80 Years
- Sexes
- All